EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression

Linda Zeng, Jingxian Shu, Shuping Zhong, Xin Dong, Yongjian Wu, Xi Huang

Molecular Therapy · 2026-10 · 34 (10) · 6163

DOI: 10.1016/j.ymthe.2026.08.040 ↗

Kurz gefasst

Korrektur in der Zeitschrift Molecular Therapy, 2026-10. Verfasst von Linda Zeng und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zeng, L., Shu, J., Zhong, S., Dong, X., Wu, Y., & Huang, X. (2026). Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression. Molecular Therapy, 34(10), 6163. https://doi.org/10.1016/j.ymthe.2026.08.040

Vancouver

Zeng L, Shu J, Zhong S, Dong X, Wu Y, Huang X. Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression. Molecular Therapy. 2026;34(10):6163. doi:10.1016/j.ymthe.2026.08.040

BibTeX
@article{Zeng2026,
  author = {Zeng, Linda and Shu, Jingxian and Zhong, Shuping and Dong, Xin and Wu, Yongjian and Huang, Xi},
  title = {Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression},
  journal = {Molecular Therapy},
  year = {2026},
  volume = {34},
  number = {10},
  pages = {6163},
  doi = {10.1016/j.ymthe.2026.08.040}
}
Kostenlos starten →